Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects

NCT02641301 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Bypass Complications

Interventions

DRUG: Sustained release morphine sulfate, 30 mg

Sponsor

Hopital Lariboisière